Compounds > glycyrrhizic acid
Page last updated: 2024-08-21

glycyrrhizic acid and Infarction, Middle Cerebral Artery

glycyrrhizic acid has been researched along with Infarction, Middle Cerebral Artery in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lv, X; Zhang, H; Zhang, Y1
Fang, WR; Guo, C; Li, YM; Lu, HD; Sun, JG; Wang, F; Yang, CQ; Zhang, YD; Zhao, HD; Zhao, YL; Zhou, JS; Zhu, JR1
Barakat, W; El-Maraghy, NN; Safwet, N; Zakaria, MN1
Cai, L; Dong, H; Gong, G; Hu, L; Wu, W; Xiang, L; Yin, L; Yuan, L1
Feng, T; Lin, Y; Weng, Z; Wu, Y; Zhang, J; Zhou, T1
Chen, L; Chu, K; Huang, M; Li, H; Que, J; Xu, W; Ye, M; Zhang, Y1
Chung, SP; Chung, YE; Kavoussi, A; Kim, CH; Lee, JH; Park, I; Seo, J; Yoon, EJ; You, JS1
Han, PL; Jin, Y; Kim, ID; Kim, SW; Lee, HK; Lee, JK; Park, S; Shin, JH1
Hou, SZ; Li, Y; Wang, X; Wang, ZY; Xu, Y; Zhu, XL1

Other Studies

9 other study(ies) available for glycyrrhizic acid and Infarction, Middle Cerebral Artery

ArticleYear
Neuroprotective effect of Trichosanthes kirilowii cassia twig on cerebral ischemia-reperfusion injury in rats.
    Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:4(Special)

    Topics: Animals; Blood-Brain Barrier; Brain; Bridged-Ring Compounds; Flavanones; Glucosides; Glycyrrhizic Acid; Infarction, Middle Cerebral Artery; Male; Monoterpenes; Neuroprotective Agents; Plant Components, Aerial; Plant Extracts; Rats; Recovery of Function; Reperfusion Injury; Trichosanthes

2018
Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation.
    Acta pharmacologica Sinica, 2018, Volume: 39, Issue:11

    Topics: Animals; Berberine; Brain; Brain Edema; Down-Regulation; Glycyrrhizic Acid; HMGB1 Protein; Infarction, Middle Cerebral Artery; Interleukin-1beta; Interleukin-6; Male; Mice, Inbred C57BL; Neuroprotective Agents; NF-kappa B p50 Subunit; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2018
Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade.
    European journal of pharmacology, 2014, Feb-05, Volume: 724

    Topics: Adaptor Proteins, Vesicular Transport; Animals; Behavior, Animal; Benzimidazoles; Biphenyl Compounds; Brain; Brain Ischemia; Cytokines; Down-Regulation; Glycyrrhizic Acid; Infarction, Middle Cerebral Artery; Interferon Regulatory Factor-3; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Neuroprotective Agents; Tetrazoles; Toll-Like Receptor 2; Toll-Like Receptor 4; Transcription Factor RelA

2014
Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Animals; Antioxidants; Apoptosis; Brain Ischemia; Cerebral Infarction; Glycyrrhizic Acid; HMGB1 Protein; Infarction, Middle Cerebral Artery; Inflammation; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Neuroprotective Agents; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats, Sprague-Dawley; Reperfusion Injury

2014
Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway.
    Brain research, 2014, Sep-25, Volume: 1582

    Topics: Animals; Apoptosis; Brain; Brain Ischemia; Disease Models, Animal; Glycyrrhizic Acid; HMGB1 Protein; Infarction, Middle Cerebral Artery; Interleukin-17; Male; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Neurons; Neuroprotective Agents; Random Allocation; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4

2014
Blood-brain barrier permeability of Gualou Guizhi granules and neuroprotective effects in ischemia/reperfusion injury.
    Molecular medicine reports, 2015, Volume: 12, Issue:1

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Capillary Permeability; Chalcones; Citrulline; Drugs, Chinese Herbal; Glucosides; Glycyrrhizic Acid; Infarction, Middle Cerebral Artery; Male; Monoterpenes; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury

2015
Hypothermia inhibits the propagation of acute ischemic injury by inhibiting HMGB1.
    Molecular brain, 2016, 08-20, Volume: 9, Issue:1

    Topics: Acute Disease; Animals; Antibodies, Neutralizing; Antigens, Nuclear; Brain Infarction; Brain Ischemia; Cytokines; Glycyrrhizic Acid; HMGB1 Protein; Hypothermia, Induced; Infarction, Middle Cerebral Artery; Inflammation Mediators; Injections, Intraventricular; Male; Nerve Tissue Proteins; Rats, Wistar

2016
Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion.
    Neurobiology of disease, 2012, Volume: 46, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Glycyrrhizic Acid; HMGB1 Protein; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Phosphorylation; Primary Cell Culture; Rats; Rats, Sprague-Dawley

2012
Ameliorative effects of diammonium glycyrrhizinate on inflammation in focal cerebral ischemic-reperfusion injury.
    Brain research, 2012, Apr-04, Volume: 1447

    Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Glycyrrhizic Acid; Infarction, Middle Cerebral Artery; Inflammation; Male; Mice; Random Allocation; Reperfusion Injury; Treatment Outcome

2012